Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYOnconova Affirms Planned Completion of Pivotal Phase 3 INSPIRE Study of Rigosertib in Myelodysplastic Syndromes by 1H20 And Provides Research & Development UpdatePREV STORYThe global pre-clinical CROs market is expected to reach US$ 8,412.9 Mn in 2027 from US$ 4,282.42 Mn in 2018